Introducing Cortellis Drug Discovery Intelligence

Welcome to next generation Integrity. It’s now easier than ever to tap into critical preclinical data to better inform R&D decisions.
To avoid wasting valuable resources developing drugs that will fail, it’s crucial to identify the likelihood of success as early as possible. However, collating the necessary data to perform this analysis is a constant challenge.

Avoid late-stage failures by accessing the broadest, deepest, most accurate source of R&D intelligence that has been manually curated, validated, and shared using a solution built by scientists for scientists. Cortellis Drug Discovery Intelligence, focuses exclusively on pharma and drug development intelligence, harmonizing and integrating essential biological, chemical, and pharmacological data from disparate sources into a single platform.

Here are some of the enhancements users are most excited about:

• New filters
  “The filters are much better than the old Integrity. It takes less time and is easy to check.”
  Information Professional
  Mid-sized Pharma, Japan

• Easy to use
  “Well done! I’m impressed with the comprehensive presentation of results on one page, with a quick access to patents and literature.”
  Sr. Director Structural Chemistry
  Mid-sized Pharma, USA

• New search capabilities
  “I can use quick search to get a holistic view of what’s known: targets, drugs, patents, animal models…The critical piece is the linking of all the data around one target and being able to see those connections.”
  Sr. Scientist, Chemistry
  Top 20 Pharma, USA

• Modern
  “I’m the guy that my colleagues pester to do their searches in Integrity. You guys have made a product that looks like somebody can just pick it up and want to use it. That is going to make my job a lot easier”
  Principal Scientist, Bioinformatics
  Top 20 Pharma, USA